Bi-potential precursor cells use environmental cues to determine their appropriate cell fate in virtually every developmental step in biology. An immunological example is the differentiation of bi-potential CD4 + CD8 + (double-positive (DP)) cells in the thymus into either CD4-or CD8-lineage T cells based on the specificity of their TCRs for intra-thymic ligands 1 . DP thymocytes are the first cells to express αβTCRs on their cell surfaces and require TCR signaling to differentiate further 1 . However, only TCRs that engage intra-thymic ligands signal DP thymocytes to differentiate into mature CD4 + single-positive (SP4) T cells or CD8 + single-positive (SP8) T cells, which is referred to as 'positive selection' 2 .
How thymocyte lineage fate is determined during positive selection is best described by the kinetic signaling model of T cell differentiation 2, 20, 21 . In the kinetic signaling model, TCR signaling of DP thymocytes specifically terminates Cd8 expression 22 , causing surface expression of CD8 to decline and CD8-dependent TCR signaling to cease. Cessation of TCR signaling allows intrathymic cytokines such as interleukin 7 (IL-7) to signal Runx3d expression, which specifies the CD8-lineage fate, induces CD8 re-expression and drives thymocyte differentiation into mature CD8 + cytotoxiclineage T cells [23] [24] [25] . Thus, the generation of CD8 + T cells during MHC I positive selection requires signaling by both TCRs and intra-thymic cytokines, and it requires coordination of those events so that TCR signaling ends in time for cytokines to signal Runx3d expression. Despite its intricacies, lineage-fate errors do not normally occur during MHC I positive selection. However, the actual duration times of TCR and cytokine signaling during MHC I positive selection have never been measured, and it is not known why lineage errors do not occur.
We sought to determine the time required for MHC I positive selection in the thymus and to understand how lineage-fate errors are avoided or prevented. We found that the duration times of both TCR signaling and cytokine signaling during MHC I positive selection varied with TCR signal intensity but varied inversely with one another, so that the overall duration of MHC I positive selection was similar for all TCRs. We identified a compensatory mechanism (signaling compensation) that dynamically adjusted TCR-cytokine signaling times during normal MHC I positive selection to insure correct CD8-lineage assignments but could be circumvented by 1 4 1 6 VOLUME 17 NUMBER 12 DECEMBER 2016 nature immunology A r t i c l e s experimental manipulations that abnormally prolonged MHC I TCR signaling to the point that it induced expression of ThPOK and prevented induction of Runx3d 14, 26, 27 . Thus, our results quantify the timing and duration of TCR and cytokine signals driving MHC I positive selection in the thymus and identify signaling compensation as a previously unknown mechanism that prevents lineage-fate errors during normal MHC I positive selection.
RESULTS

Two distinct phases of MHC I positive selection
We sought to determine the duration time of TCR and cytokine signals during MHC I positive selection in the thymus and to assess their effect on subsequent lineage-fate 'choices' . We first examined thymocytes from mice with homozygous deficiency in MHC II (H2-Ab1 −/− ; called 'MHCII −/− ' here) that also expressed green fluorescent protein (GFP), from an allele encoding the recombinase RAG2 (Rag2 GFP ), as their RAG2-GFP content steadily diminishes with time during MHC I positive selection 28 . We also used surface expression of the activation marker CD69 and the chemokine receptor CCR7 to track MHC I positive selection because these markers were not expressed in pre-selection thymocytes and were upregulated differentially during positive selection (Fig. 1a) . Differential expression of CD69 and CCR7 revealed six stages of MHC I positive selection, with stage 1 consisting of TCR-unsignaled pre-selection thymocytes and stages 2-6 consisting of thymocytes that had been signaled to undergo MHC I positive selection ( Fig. 1a and Supplementary  Fig. 1 ). Notably, thymocytes in stages 2-6 contained steadily decreasing amounts of RAG2-GFP, which indicated that TCR-signaled thymocytes at stage 2 differentiated sequentially into stage 3, then stage 4 and then stage 5 and, ultimately, into stage 6 ( Fig. 1b and  Supplementary Fig. 1 ). Thus, stages 2-6 reflect precursor-progeny relationships among thymocytes at sequential stages of MHC I positive selection.
We then examined CD8 surface expression at each sequential stage of MHC I positive selection. CD8 surface expression initially declined during stages 2-4 and then abruptly increased during stages 4-6, with CD8 expression being fully restored by stage 6 (Fig. 1b) . The marked changes in CD8 expression defined two sequential phases of MHC I positive selection, with phase 1 being characterized by declining CD8 expression on thymocytes that were CCR7 neg-lo , and phase 2 being characterized by increasing CD8 expression on thymocytes that were CCR7 med-hi .
Concurrent assessment of the expression of CD4 and CD8 on stage 2-6 thymocytes revealed the complicated CD4-CD8 phenotypic pathway that TCR-signaled thymocytes follow during MHC I positive selection 29 ( Fig. 1c and Supplementary Fig. 1 ). Expression of CD4 and CD8 did not clearly distinguish phase 1 thymocytes from phase 2 thymocytes because both were present among DP and CD4 + CD8 lo intermediate (IM) subsets (Fig. 1c) . In each subset, we were able to distinguish phase 1 and phase 2 thymocytes by expression of CCR7 and/or RAG2-GFP. For example, CD69 + DP thymocytes included both CCR7 lo RAG2-GFP hi (phase 1) cells and CCR7 hi RAG2-GFP lo (phase 2) cells (Fig. 1d) . Such heterogeneity was not caused by TCR diversity, as DP thymocytes bearing the monoclonal OT-I TCR (transgenic TCR selected by MHC I) also included both phase 1 cells and phase 2 cells (Fig. 1e) . GFP   CD4   18  16  14  12  10  8  6  4  2  0   8  7  6  5  4  3  2  1  0  Stage   CD69   CCR7   1  2  3  4  5 Our results indicate that MHC I positive selection proceeds in two sequential phases that are defined by dynamic changes in CD8 co-receptor expression and are distinguishable by quantitative differences in CCR7 expression.
Runx3d induction during positive selection
Because Runx3d is the transcription factor that specifies CD8-lineage fate, we next determined when Runx3d is expressed during MHC I positive selection. For this determination, we introduced the Runx3d YFP reporter allele (in which yellow fluorescent protein (YFP) is expressed from a Runx3d allele) 26 into RAG2-deficient OT-I mice. Runx3d-YFP was first detectable only in stage 4 cells, with expression increasing in stages 5-6 (Fig. 2a) . To gain further insight into Runx3d expression during MHC I positive selection, we also assessed Runx3d-YFP expression in OT-I thymocyte populations defined by expression of CD4 and CD8 (Fig. 2b) . Runx3d-YFP − cells and Runx3d-YFP + cells were both present in DP and IM OT-I thymocyte subsets, with IM OT-I cells being further subcategorized, for greater discrimination, into IM 1 , IM 2 and IM 3 subsets on the basis of decreasing CD8 surface expression ( Fig. 2b and Supplementary Fig. 2 ). Quantifying CCR7 expression on Runx3d-YFP − and Runx3d-YFP + cells in each thymocyte subset confirmed that Runx3d-YFP − thymocytes were phase 1 cells that sequentially differentiated from DP>IM 1 >IM 2 >IM 3 , and that Runx3d-YFP + thymocytes were phase 2 cells that sequentially differentiated from IM 3 >IM 2 >IM 1 >DP>SP8 (Fig. 2b and Supplementary  Fig. 2) . Thus, Runx3d expression does not begin until stage 4, at which point cells have the least surface expression of CD8, and increases throughout phase 2 differentiation.
Runx3d induction has previously been shown to be signaled by intrathymic cytokines 23, 24 and to be inhibited by the cytokine-signaling suppressor SOCS1 (refs. 24,27,30) . We observed that transgenic expression of SOCS1 (SOCS1 Tg ) 31 almost completely abrogated Runx3d-YFP expression and therefore impaired phase 2 differentiation (Fig. 2c) , as very few CD69 + DP OT-I SOCS1 Tg thymocytes were CCR7 hi (Fig. 2c) .
Moreover, the few OT-I SOCS1 Tg thymocytes that became stage 5-6 cells did not normally upregulate expression of CD8 and Runx3d-YFP (Fig. 2d) . In contrast, SOCS1 Tg expression did not affect phase 1, as Runx3d-YFP − cells normally increased CCR7 expression during phase 1 differentiation from DP>IM 1 >IM 2 >IM 3 (Fig. 2c) .
Our results demonstrate that phase 1 differentiation proceeds independently of cytokine signaling, whereas phase 2 differentiation is driven by cytokine signals that induce Runx3d expression. Because they do not express Runx3d, MHC-I-signaled phase 1 thymocytes can be considered 'lineage uncertain' , whereas phase 2 thymocytes that do express Runx3d are 'CD8 lineage committed' .
Factors determining phase 1 duration
Because phase 1 differentiation is driven by TCR signaling, phase 1 duration might be affected by TCR signaling intensity. To assess this possibility, we used RAG-deficient H-2 b female mice containing monoclonal thymocyte populations bearing various transgenic TCRs (HY, F5, P14 and OT-I) that signal MHC I positive selection with different intensities. As reflected by surface expression of the negative regulator CD5 on stage 2 (CD69 + CCR7 − ) thymocytes that had just received TCR signals, the in vivo signaling intensities of transgenic TCRs formed a descending hierarchy of OT-I > P14 > F5 > HY ( Fig. 3a and Supplementary Fig. 3a) . Interestingly, thymocyte profiles of mice with transgenic TCR expression revealed that the surface abundance of CD8 on CD4 + CD69 + IM thymocytes decreased as TCR signaling intensity increased (Fig. 3b) . To quantify surface CD8 on IM thymocytes bearing different transgenic TCRs, we normalized CD8 protein abundance on TCR-signaled CD69 + IM thymocytes to CD8 expression on their own pre-selection DP thymocytes. Notably, CD8 expression on IM thymocytes was reduced least on HY thymocytes and was reduced most on OT-I thymocytes (Fig. 3b) , although CD8 expression in all cases was fully restored during phase 2 differentiation into SP8 cells (Fig. 3b) . Thus, TCR signaling intensity specifically determines the extent of CD8 loss during phase 1 differentiation. A r t i c l e s MHC-I-specific TCR signaling in the thymus requires both TCR and CD8 but is limited by the low amount of the protein tyrosine kinase Lck that is associated with the CD8 cytosolic tail 32, 33 . Consequently, MHC I signaling intensity might increase with greater binding of Lck to CD8. To assess this possibility, we compared thymocytes expressing endogenously encoded wild-type CD8 (CD8 wt ) or CD8 that had been re-engineered to express CD4 cytosolic tails that bind more Lck (CD8.4) 34 (Fig. 3c) . In fact, CD8 loss on IM thymocytes was greater with CD8.4 than CD8 wt whether thymocytes expressed weakly signaling F5 TCRs or strongly signaling OT-I TCRs (Fig. 3c) . Thus, low binding of Lck to wild-type CD8 limits TCR signaling intensity and CD8 loss during phase 1 differentiation.
The extent of CD8 loss during phase 1 differentiation reflects the passage of time since thymocytes were initially signaled by their TCR to terminate Cd8 transcription 22 . To confirm this, we introduced the transgene encoding RAG2-GFP into mice with transgenic TCR expression and compared the GFP content in IM thymocytes relative to that in stage 2 (CD69 + CCR7 − ) DP thymocytes in their own thymus (Fig. 3d) . As expected, RAG2-GFP content was lower in IM thymocytes than in stage 2 DP thymoyctes, but the amount of RAG2-GFP remaining in IM thymocytes with OT-I TCR was less than that remaining in IM thymocytes with HY TCR, and the remaining RAG2-GFP content of OT-I IM thymocytes was further reduced by CD8.4 (Fig. 3d) . Plotting relative CD8 expression versus relative RAG2-GFP content in IM thymocytes revealed a marked correlation (r 2 > 0.92) between these two parameters (Fig. 3d) . Given that the decrease in RAG2-GFP content in IM thymocytes is a direct measure of time that has passed since TCR signaling initiated phase 1 differentiation, these results indicate that CD8 loss on IM thymocytes is also a measure of phase 1 duration time.
Our findings suggest that CD8-dependent TCR signals initiate MHC-I-specific positive selection and continue throughout phase 1, but with steadily diminishing intensity because of progressively declining CD8 surface expression (Supplementary Fig. 3b ). Phase 1 differentiation lasted longer for OT-I thymocytes than for HY thymocytes because OT-I TCRs have higher ligand affinity and can therefore continue signaling with fewer remaining CD8 co-receptors. Phase 1 differentiation finally terminated when TCR-co-receptor signaling intensity became too weak to prevent cytokines from signaling Runx3d expression and initiating phase 2 differentiation.
Inverse relationship between phase 1 and 2 duration time It was possible to calculate the duration time in hours for each phase of MHC I positive selection because the half-life of GFP protein from the Rag2 GFP transgene declines with a linear half-life of 54-56 h (ref. 28) . Having defined phase 1 by decreasing CD8 expression and phase 2 by increasing CD8 expression, we calculated phase 1 duration times on the basis of RAG2-GFP content in IM cells with lowest CD8 (CD8 lowest ) surface expression and we calculated phase 2 duration times based on RAG2-GFP content in SP8 (stage 6) cells (Fig. 4) . Phase 1 duration times for HY thymocytes and OT-I thymocytes were 18 h and 53 h, respectively (Fig. 4) , with the latter's time being further prolonged to 67 h by strongly signaling CD8.4 co-receptors. Thus, phase 1 duration times varied directly with TCR and CD8 signaling intensity.
To our surprise, phase 2 duration times varied inversely with phase 1 duration times. Phase 2 duration times were longest (79 h) in HY thymocytes with short phase 1 times, and phase 2 duration times were shortest (20 h) in OT-I CD8.4 thymocytes with long phase 1 times. The inverse relationship between the duration times of phase 1 and phase 2 was notable, as phase 1 duration times were 2.5-to 3-fold longer for OT-I thymocytes than for HY thymocytes, whereas phase 2 duration times were 2.5-to 3-fold shorter (Fig. 4) .
The inverse relationship between the differentiation times of phase 1 and phase 2 was unexpected. Given that CD8 loss during phase 1 was greatest for OT-I thymocytes, we had expected CD8 re-expression during phase 2 to be slowest for OT-1 thymocytes. However, the opposite was true: despite starting phase 2 differentiation with the least CD8, OT-I thymocytes completed phase 2 differentiation more quickly than HY thymocytes did (32 h versus 79 h) (Fig. 4) . We considered the possibility that phase 2 differentiation time might reflect cytokine signaling intensity and that cytokine signaling intensity might be influenced by TCR signaling duration. Indeed, pre-selection DP thymocytes are cytokine unresponsive as a result of high expression of Socs1 and absent expression of Il7r (which encodes the cytokine receptor IL-7Rα) 30, 35, 36 , but TCR signaling induces DP thymocytes to terminate Socs1 expression and re-initiate Il7r expression 24, 30 . As a result, Socs1 mRNA content might be expected to steadily decrease and IL-7Rα surface expression to steadily increase during phase 1 differentiation, causing thymocytes to acquire greater and greater 'cytokine-response potential' the longer phase 1 differentiation persists ( Supplementary Fig. 4) .
To address this notion, we quantified Socs1 mRNA and IL-7Rα surface expression during phase 1 differentiation of OT-I and HY thymocytes. Indeed, the decrease in Socs1 mRNA and the increase in surface IL-7Rα during phase 1 were both greater in OT-I thymocytes than in HY thymocytes (Fig. 5a) , indicating that longer phase 1 duration times do result in greater cytokine response potential.
One effect of greater cytokine-response potential might be to accelerate and increase Runx3d induction, shortening the phase 2 differentiation time (Supplementary Fig. 4) . If that were correct, then Runx3d expression would be higher throughout phase 2 differentiation in thymocytes with high-affinity than in those with lowaffinity TCRs. In fact this prediction was precisely what we observed (Fig. 5b-d) . Runx3d-YFP expression was higher in OT-I thymocytes than in HY thymocytes at both stage 5 and stage 6 (Fig. 5b) , indicating that Runx3d expression during phase 2 increases faster and to a greater amount in high-affinity OT-I thymocytes. Moreover, Runx3d mRNA expression was threefold greater in OT-I SP8 thymocytes than HY SP8 thymocytes at the conclusion of phase 2 differentiation (Fig. 5c) , and was greater in SP8 thymocytes with CD8.4 co-receptors (Fig. 5d) . We conclude that prolonged phase 1 duration times increase cytokine response potential, which quantitatively increases both the rate and magnitude of Runx3d induction to accelerate phase 2 differentiation.
Because the duration times of phase 1 and phase 2 varied inversely to one another, we then considered their effect on overall positive selection times. We were surprised to find that variations in the duration times of phase 1 and phase 2 almost completely compensated for one another, as overall MHC I positive selection times were relatively constant (differing by less than 20%) among thymocytes with TCR-co-receptor signals of different intensity (Fig. 4) .
Phase 1 prolongation results in lineage errors
Because phase 1 thymocytes did not express Runx3d and were lineage uncertain, we wondered whether prolonging phase 1 to increase the duration of lineage uncertainty might cause lineage 'choice' errors. To determine whether MHC I selected thymocytes could erroneously express ThPOK, we introduced the Thpok GFP reporter 37 into OT-I Rag2 −/− MHCII −/− mice that expressed only MHC I ligands. Interestingly, ThPOK-GFP expression was significantly expressed only in IM thymocytes from OT-1 CD8.4 mice that had the longest phase 1 differentiation time (67 h) in this study ( Fig. 6a and Supplementary  Fig. 5a ). In fact, OT-I CD8.4 thymocytes that were ThPOK + continuously lost CD8 surface expression during positive selection and differentiated into SP4 thymocytes (Fig. 6b) . In contrast, OT-I CD8.4 thymocytes that remained ThPOK − re-expressed surface CD8 protein during stages 5 and 6 and differentiated into SP8 thymocytes (Fig. 6b) . Notably, the phase 1 differentiation time of OT-I CD8.4 thymocytes that remained ThPOK − was 63.6 h, which was significantly longer (P < 0.05) than that of OT-I CD8 wt thymocytes (Fig. 6b) . Thus, stronger signaling CD8.4 co-receptors prolonged phase 1 duration for OT-I thymocytes whether or not ThPOK was expressed, indicating that phase 1 prolongation was not a result of ThPOK. Instead, we suggest that prolonged MHC I TCR signaling induces ThPOK expression.
Consistent with the presence of CD4 + ThPOK-GFP + cells in the thymus, a small but distinct population of CD4 + ThPOK-GFP + T cells were present in the periphery of OT-I CD8.4 mice (Fig. 6a and  Supplementary Fig. 5a,b) . Such OT-I CD4 + T cells expressed less duration time = (100 -relative RAG2-GFP) / 0.9. The RAG2-GFP content in just-signaled (CD69 + CCR7 − ) DP thymocytes was set as 100%. Phase 1 duration time was calculated using relative RAG2-GFP expression on IM (CD69 + CD4 + CD8 lowest ) thymocytes, and the duration time of overall positive selection was calculated using relative RAG2-GFP expression on stage 6 SP8 (CCR7 + CD8 SP) thymocytes. Phase 2 duration time was calculated as the difference between overall positive selection and phase 1 duration times (middle and bottom). *P < 0.05, **P < 0.01 and ***P < 0.001 (Student′s two-tailed t test). Data are representative of four independent experiments (mean and s.e.m. of n = 5, 6, 4, 5).
A r t i c l e s
ThPOK-GFP than did conventional CD4 + T cells from C57BL/6 mice ( Supplementary Fig. 5a ), but nevertheless possessed helper function as they upregulated surface CD40L expression following stimulation via TCR plus the costimulatory molecule CD28 (Fig. 6c  and Supplementary Fig. 5c ).
The number of CD4 + lymph node T cells (LNT cells) detected in OT-I CD8.4 mice (Supplementary Fig. 5b ) likely under-estimated the rate of lineage specification errors, because TCR-co-receptor mismatching would impair TCR signaling and cell survival in the periphery. Indeed, CD5 expression was lower on CD4 + OT-I T cells than on CD8 + OT-I T cells (Supplementary Fig. 5d ), the reverse of normal CD4 + and CD8 + T cells, indicating that TCR signaling by peripheral self ligands was impaired in TCR-co-receptor mis-matched OT-I T cells. Moreover, recent thymic emigrants (that is, RAG2-GFP + T cells) constituted fully 40% of CD4 + OT-I T cells but less than 10% of CD8 + OT-I T cells, indicating impaired peripheral survival of mis-matched OT-I CD4 + T cells (Supplementary Fig. 5d ).
To confirm that lineage-specification errors in OT-I CD8.4 thymocytes are the result of prolonged TCR signaling and are not unique to CD8.4 thymocytes, we prolonged the phase 1 differentiation time of OT-I CD8 wt thymocytes by making them CD5 deficient to remove a potent inhibitor of TCR signaling 38 (Fig. 6d) . To ensure that OT-I Cd5 −/− thymocytes were MHC I signaled, we used CD5-deficient OT-I (CD45.2 + ) bone marrow stem cells to reconstitute lethally irradiated MHCII −/− (CD45.1 + ) host mice (Fig. 6d) . CD5 deficiency resulted in significantly greater CD8 loss and significantly prolonged phase 1 differentiation of OT-I IM thymocytes (Fig. 6e,f) . Notably, prolonged phase 1 duration was again associated with the appearance of mismatched OT-I CD4 + LNT cells (Fig. 6d and Supplementary Fig. 5e ).
Time limit for error-free CD8 lineage specification Finally, we asked whether there existed a maximum TCR signaling time limit for MHC-I-signaled thymocytes to accurately 'choose' the CD8-lineage fate. To answer this question, we plotted the frequency of peripheral CD4 + LNT cells versus phase 1 duration time in the thymus for Rag2 −/− mice with the various transgenic TCRs (Fig. 7) . In mice with phase 1 duration times of less than 53 h, MHC-I-selected CD4 + T cells were undetectable (Fig. 7) . In contrast, mice with phase 1 duration times greater than 60 h contained MHC-I-selected CD4 + T cells in frequencies of 0.6-2.25%, despite impaired peripheral survival of T cells with mismatched TCR and co-receptors (Fig. 7) . Phase 1 duration times of 53-60 h represented an inflection point between error-free fate 'choices' and error-prone lineage fate 'choices' (Fig. 7) . Thus, 53 h is the maximum TCR signaling time limit for consistently error-free CD8-lineage 'choice' during MHC I positive selection, with longer MHC I TCR signaling times becoming increasingly error prone.
DISCUSSION
By deconstructing MHC I positive selection into its component steps, we have determined the sequence, timing and duration of signaling events that drive MHC I positive selection and result in CD8-lineage fate assignment. MHC I positive selection proceeded in two phases, with phase 1 being driven by TCR signaling and phase 2 being driven by cytokine signaling. In normal thymocytes, TCR signaling duration varied between 18 h and 53 h depending on TCR-ligand affinity, whereas cytokine signaling duration varied between 32 h and 79 h depending on the Runx3d induction rate, with faster and greater Runx3d induction shortening cytokine signaling times. The dynamic adjustment of TCR-cytokine signaling times during MHC I positive selection is called 'signaling compensation' and provides normal thymocytes with the amount and duration of cytokine signals needed to induce Runx3d and drive differentiation into CD8 + T cells. Notably, signaling compensation required MHC I TCR signaling to persist for no more than 53 h, which was the maximum MHC I TCR signaling time in normal thymocytes. Signaling compensation was circumvented by experimental manipulations that prolonged MHC I TCR signaling beyond 53-60 h, which induced ThPOK expression and prevented Runx3d expression, causing erroneous differentiation into CD4-helper-lineage T cells.
Signaling compensation is intrinsic to individual thymocytes and dynamically adjusts cytokine signaling times during MHC I positive selection. The basis of signaling compensation derives from the unique physiology of DP thymocytes. DP thymocytes receive survival signals only from their TCR, and cannot receive survival signals from intra-thymic cytokines 24, 30, 35, 36 . In fact, pre-selection DP thymocytes are cytokine unresponsive because of absent Il7r expression and uniquely high Socs1 expression 24, 35 . TCR signaling of DP thymocytes re-initiates Il7r expression and terminates Socs1 expression to permit cytokine signal transduction and subsequent Runx3d expression in positively selected thymocytes 24 . Consequently, thymocytes acquire greater and greater 'cytokine-response potential' the longer MHC-Ispecific TCR signaling persists. Thus, the mechanism of signaling compensation can be understood as follows: the longer MHC I TCR signaling persists, the greater the thymocyte cytokine-response potential, the more intense the subsequent cytokine signaling, the faster and greater Runx3d induction, and the less time required for cytokinesignaled thymocytes to differentiate into mature SP8 T cells. Thus, the Runx3d induction rate is a key factor for determining the time required for CD8 + T cell differentiation. Although cytokines induce Runx3d expression, prolonged MHC I TCR signaling induced ThPOK expression, so long as it was of sufficient duration. Error-free CD8-lineage fate during MHC I positive selection required TCR signaling to end before ThPOK expression was induced. CD8 loss during phase 1 disrupted TCR signaling because, with few exceptions, MHC-I-specific TCRs on DP thymocytes required CD8 to engage intra-thymic ligands. The few MHC-Ispecific TCRs that are CD8 independent in the thymus signal thymocyte differentiation into alternative-lineage cells, such as natural killer T cells 39 , but not into CD8-lineage T cells. It is a curious but critical feature of MHC I positive selection that signaled DP thymocytes immediately begin losing surface CD8 protein expression until it becomes too low to sustain continued signaling by CD8-dependent TCRs. The amount of time TCR signaling continues before being disrupted varies for different TCRs because TCRs with higher binding affinities require fewer CD8 co-receptors to continue signaling. Nevertheless, the maximum time that MHC I TCR signaling persisted in normal thymocytes was ~53 h. However, experimental manipulations such as genetic deletion of Cd5 or expression of CD8.4 with stronger signaling resulted in prolongation of OT-I TCR signaling beyond 53 h, as they reduced the number of CD8 co-receptors required for continued TCR signaling. Notably, the result of prolonged TCR signaling was the appearance of ThPOK + thymocytes and CD4-lineage-fate errors, events that did not occur in unmanipulated thymocytes.
We suspect it is not simply fortuitous that MHC I TCR signaling is disrupted in normal thymocytes before ThPOK expression 80 A r t i c l e s can be induced. Instead, we think that CD8 proteins have evolved to be weakly signaling co-receptor molecules whose surface expression decreases rapidly enough during MHC I positive selection to disrupt TCR signaling before ThPOK expression is induced. We also suspect that the regulatory elements controlling ThPOK expression have evolved to be activated by TCR signals of longer duration and greater intensity than can normally be achieved by CD8-dependent TCRs during positive selection. Consequently, we think that CD8 co-receptor proteins and ThPOK molecules might have co-evolved to minimize lineage errors during MHC I positive selection. Our results provide an explanation for conflicting conclusions about the role of TCR signaling in CD8-lineage specification [40] [41] [42] . It is now appreciated that the CD8-lineage fate is not specified by MHC I TCR signals but is instead specified by cytokine signals that induce Runx3d expression 24 . Indeed, we found that Runx3d expression was not induced by TCR signaling during phase 1 but was induced by cytokine signaling during phase 2. Nonetheless, MHC I TCR signal duration indirectly affected the induction of Runx3d expression by influencing thymocyte cytokine-response potential. Consequently, we think that previous studies concluding that MHC I TCR signals specify the CD8-lineage fate failed to appreciate the fact that the influence of TCR signaling on CD8 specification is only indirect 40, 42 . In addition, we found that not all DP thymocytes are pre-selection cells, as CD8-lineage-committed thymocytes during phase 2 differentiation may fall within the DP gate. Indeed, unlike pre-selection DP thymoyctes, which were invariably CCR7 − , DP thymocytes that were CCR7 int-hi were in the process of upregulating Runx3d expression and surface expression of CD8 during phase 2 differentiation.
In conclusion, our results substantially enhance the understanding of MHC I positive selection and CD8-lineage fate by revealing how TCR and cytokine signaling are coordinated during MHC I positive selection. By dynamically adjusting the rate and magnitude of Runx3d induction by intra-thymic cytokines, signaling compensation ensures correct CD8-lineage assignments to thymocytes during normal MHC I positive selection. Thus, TCR and cytokine signaling times are dynamically regulated during normal MHC I positive selection to generate CD8-lineage T cells and to avoid lineage-fate errors.
METHODS
Methods and any associated references are available in the online version of the paper. 
